EVENTS
Tuesday, March 9, 2021
7:00am EST

CEO Saundra Pelletier will present at the H.C. Wainwright Global Life Sciences Conference, providing an update on the commercialization of its non-hormonal, on-demand contraceptive, PhexxiPhexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel.

STOCK INFORMATION
NASDAQEVFM
PRESS RELEASES
Mar 29, 2021

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 17,142,857 shares of its common stock at $1.75 per share. Evofem's...

Mar 24, 2021

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a price to the public of $1.75 per share. The...

Mar 24, 2021

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to offer and sell, subject to market and other conditions, $30 million of shares of its common stock in an underwritten...

Mar 17, 2021

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that "Get Phexxi," its national direct-to-consumer (DTC) campaign aimed at broadening awareness of its non-hormonal, on-demand birth...

Mar 16, 2021

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced publication of the pivotal manuscript from the AMPREVENCE clinical trial in the highly respected American Journal of Obstetrics and...

Read More